微生物进化医学:从理论到临床实践
本文综述了进化医学框架在微生物领域的应用,旨在通过整合生态学、进化生物学、微生物学、生物信息学和临床专业知识,预测和调控微生物对人类健康的影响。文章聚焦于应对三大挑战:检测微生物传播、预测抗菌药物耐药性,以及理解微生物组背景下微生物-微生物和人类-微生物在健康与疾病中的相互作用。
要点
- 进化医学框架可预测和调控微生物对健康的影响
- 重点应对微生物传播检测和抗菌药物耐药性预测
- 关注微生物组中微生物间及与宿主的相互作用
核心结论
- 进化医学框架有望通过整合多学科方法应对微生物传播、耐药性和微生物组相互作用等挑战。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- 传统识别和消除病原体的方法对于应对变化的疾病格局已显不足。
- 人类健康的主要挑战包括免疫和炎症改变驱动的非传染性慢性病,以及耐药微生物引起的传染性感染。
临床怎么用
- 临床可借助进化医学框架预测和调控微生物组对健康的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Medicine and clinical microbiology have traditionally attempted to identify and eliminate the agents that cause disease. However, this traditional approach is becoming inadequate for dealing with a changing disease landscape. Major challenges to human health are non-communicable chronic diseases, often driven by altered immunity and inflammation, and communicable infections from agents which harbour antibiotic resistance. This Review focuses on the so-called evolutionary medicine framework, to study how microbial communities influence human health. The evolutionary medicine framework aims to predict and manipulate microbial effects on human health by integrating ecology, evolutionary biology, microbiology, bioinformatics, and clinical expertise. We focus on the potential of evolutionary medicine to address three key challenges: detecting microbial transmission, predicting antimicrobial resistance, and understanding microbe-microbe and human-microbe interactions in health and disease, in the context of the microbiome.
引用
- Andersen SB, Shapiro BJ, Vandenbroucke-Grauls C, et al. Microbial evolutionary medicine: from theory to clinical practice. Lancet Infect Dis. 2019. PMID: 31053492. doi:10.1016/S1473-3099(19)30045-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。